Powers M - Search Results

1

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group; Topper S. Nykamp K, et al. Among authors: powers m. Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Genet Med. 2017. PMID: 28492532 Free PMC article.

2

Correction: Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group; Topper S. Nykamp K, et al. Among authors: powers m. Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9. Genet Med. 2020. PMID: 31346256 Free PMC article.

3

Low-level constitutional mosaicism of a de novoBRCA1 gene mutation.

Friedman E, Efrat N, Soussan-Gutman L, Dvir A, Kaplan Y, Ekstein T, Nykamp K, Powers M, Rabideau M, Sorenson J, Topper S. Friedman E, et al. Among authors: powers m. Br J Cancer. 2015 Feb 17;112(4):765-8. doi: 10.1038/bjc.2015.14. Epub 2015 Jan 29. Br J Cancer. 2015. PMID: 25633036 Free PMC article.

4

The molecular pathology of sarcomas.

Powers M, Zhang W, Lopez-Terrada D, Czerniak BA, Lazar AJ. Powers M, et al. Cancer Biomark. 2010;9(1-6):475-91. doi: 10.3233/CBM-2011-0170. Cancer Biomark. 2010. PMID: 22112491

5

KRAS mutation detection in colorectal cancer by a commercially available gene chip array compares well with Sanger sequencing.

French D, Smith A, Powers MP, Wu AH. French D, et al. Clin Chim Acta. 2011 Aug 17;412(17-18):1578-81. doi: 10.1016/j.cca.2011.05.001. Epub 2011 May 7. Clin Chim Acta. 2011. PMID: 21575616

6

Gliosarcoma arising from an oligodendroglioma (oligosarcoma).

Hiniker A, Hagenkord JM, Powers MP, Aghi MK, Prados MD, Perry A. Hiniker A, et al. Among authors: powers mp. Clin Neuropathol. 2013 May-Jun;32(3):165-70. doi: 10.5414/NP300577. Clin Neuropathol. 2013. PMID: 23254140

7

Detection of myxoid liposarcoma-associated FUS-DDIT3 rearrangement variants including a newly identified breakpoint using an optimized RT-PCR assay.

Powers MP, Wang WL, Hernandez VS, Patel KS, Lev DC, Lazar AJ, López-Terrada DH. Powers MP, et al. Mod Pathol. 2010 Oct;23(10):1307-15. doi: 10.1038/modpathol.2010.118. Epub 2010 Jun 25. Mod Pathol. 2010. PMID: 20581806 Free article.

8

Myxoid liposarcoma: a case report of a sentinel metastasis to the parotid gland with molecular confirmation.

Been L, Olar A, Powers MP, López-Terrada D, Lauririca R. Been L, et al. Diagn Cytopathol. 2011 Oct;39(10):780-3. doi: 10.1002/dc.21553. Diagn Cytopathol. 2011. PMID: 22473934

9

A common 8q (MYC) amplification detected in a multifocal anaplastic astrocytoma by SNP array karyotyping.

Felicella MM, Hagenkord JM, Kash SF, Powers MP, Berger MS, Perry A. Felicella MM, et al. Among authors: powers mp. Clin Neuropathol. 2012 Jul-Aug;31(4):210-5. doi: 10.5414/np300484. Clin Neuropathol. 2012. PMID: 22720694

10

The ever-changing world of gene fusions in cancer: a secondary gene fusion and progression.

Powers MP. Powers MP. Oncogene. 2019 Nov;38(47):7197-7199. doi: 10.1038/s41388-019-1057-2. Epub 2019 Oct 15. Oncogene. 2019. PMID: 31616060 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

942 results

Search Page

Filters